tumor-antigen-specific lymphocytes (Corixa)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nametumor-antigen-specific lymphocytes (Corixa)

Drug Alias Namedendritic cell cancer therapy (Corixa/CPX)tumor-antigen-specific lymphocytes (CPX)

ClassificationCell and gene therapy > Cell therapyVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCorixa Corp

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesCPX Corp Corixa Corp

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A